Finally, Tocqueville's biggest closed positions included Barrick Gold and Kaiser Aluminum. Other closed positions of interest include Amarin (NASDAQ: AMRN ) , a late-stage cardiovascular-focused biotech company with a promising drug to lower triglycerides. Some bulls see its newly approved drug, Vascepa, as underappreciated while others are waiting to see how successful its launch is. There's speculation that the company will be acquired by a big pharmaceutical company, too.
François D. Sicart François D. Sicart is Founder and Chairman of Tocqueville Management Corporation, the general partner of Tocqueville Asset Management L.P.
1. Your English is horrible (when you have an original post).
2. You cut and paste non-stop w/out giving a reference.
3. 99% is old news.
4. You are a swing trader that mindlessly pumps AMRN.
5. You are clueless as to who the longs and shorts are on the MB.